0

    524752

    DECIPHER

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    DECIPHER LABS LIMITED Share Price Today

    Investment Returns

    Over 1 Month -5.66% Over 3 Months -20.87% Over 6 Months -20.97% Over 1 Year -41.65%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    DECIPHER LABS LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 6.90
    • P/E Ratio (TTM) -26.38
    • Beta 0.99
    • Book Value / share 8.15
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.17
    info icon alternate text

    DECIPHER LABS LIMITED Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.07
    Operating Expense 0.24
    Net Profit -0.17
    Net Profit Margin (%) -242.85
    Earnings Per Share (EPS) -0.17
    EBITDA -0.17
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.13
    Operating Expense 0.14
    Net Profit -0.01
    Net Profit Margin (%) -7.69
    Earnings Per Share (EPS) -0.01
    EBITDA -0.01
    Effective Tax Rate (%) -100.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.09
    Operating Expense 0.20
    Net Profit -0.12
    Net Profit Margin (%) -133.33
    Earnings Per Share (EPS) -0.11
    EBITDA -0.12
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.85
    Operating Expense 0.79
    Net Profit 0.06
    Net Profit Margin (%) 7.05
    Earnings Per Share (EPS) 0.06
    EBITDA 0.06
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.23
    Operating Expense 0.39
    Net Profit -0.17
    Net Profit Margin (%) -73.91
    Earnings Per Share (EPS) -0.17
    EBITDA -0.16
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 1.14
    Operating Expense 1.38
    Net Profit -0.25
    Net Profit Margin (%) -21.92
    Earnings Per Share (EPS) -0.24
    EBITDA -0.22
    Effective Tax Rate (%) -4.16
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.85
    Operating Expense 1.32
    Net Profit -0.44
    Net Profit Margin (%) -51.76
    Earnings Per Share (EPS) -0.44
    EBITDA -0.42
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 3.53
    Operating Expense 3.53
    Net Profit 0.02
    Net Profit Margin (%) 0.56
    Earnings Per Share (EPS) 0.02
    EBITDA 0.04
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 0.81
    Operating Expense 1.24
    Net Profit -2.62
    Net Profit Margin (%) -323.45
    Earnings Per Share (EPS) -2.59
    EBITDA -2.58
    Effective Tax Rate (%) 0.75
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.99
    Operating Expense 0.68
    Net Profit 0.36
    Net Profit Margin (%) 36.36
    Earnings Per Share (EPS) 0.36
    EBITDA 0.41
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 22.63
    ROE % 1.16
    ROCE % -4.66
    Total Debt to Total Equity 0.01
    EBITDA Margin -2.51
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 21.64
    ROE % -6.75
    ROCE % -3.11
    Total Debt to Total Equity 0.02
    EBITDA Margin -0.71
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 22.98
    ROE % 15.91
    ROCE % 9.46
    Total Debt to Total Equity 0.24
    EBITDA Margin 7.03
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 23.93
    ROE % 55.79
    ROCE % 38.01
    Total Debt to Total Equity 0.71
    EBITDA Margin 20.97
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 13.55
    ROE % 8.35
    ROCE % 10.82
    Total Debt to Total Equity 1.05
    EBITDA Margin 7.43
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 8.40
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.01
    EBITDA Margin -49.41
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 8.84
    ROE % 0.16
    ROCE % 0.16
    Total Debt to Total Equity 0.00
    EBITDA Margin 1.13
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 8.82
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -33.33
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 11.41
    ROE % 2.20
    ROCE % 2.19
    Total Debt to Total Equity 0.01
    EBITDA Margin 41.41
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 11.05
    ROE % 0.61
    ROCE % 0.72
    Total Debt to Total Equity 0.02
    EBITDA Margin 16.33
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.80
    Total Assets 25.76
    Total Liabilities 25.76
    Total Equity 22.85
    Share Outstanding 1
    Price to Book Ratio 1.25
    Return on Assets (%) -19.71
    Return on Capital (%) -21.99
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 9.31
    Total Assets 33.63
    Total Liabilities 33.63
    Total Equity 21.86
    Share Outstanding 1
    Price to Book Ratio 1.67
    Return on Assets (%) -4.98
    Return on Capital (%) -7.66
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 7.41
    Total Assets 28.16
    Total Liabilities 28.16
    Total Equity 23.20
    Share Outstanding 1
    Price to Book Ratio 1.61
    Return on Assets (%) -9.52
    Return on Capital (%) -11.1
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 15.40
    Total Assets 41.94
    Total Liabilities 41.94
    Total Equity 24.16
    Share Outstanding 1
    Price to Book Ratio 4.64
    Return on Assets (%) 27.13
    Return on Capital (%) 33.01
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 6.97
    Total Assets 38.72
    Total Liabilities 38.72
    Total Equity 13.68
    Share Outstanding 1
    Price to Book Ratio 3.03
    Return on Assets (%) 3.62
    Return on Capital (%) 6.25
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 9.17
    Total Liabilities 9.17
    Total Equity 8.48
    Share Outstanding 1
    Price to Book Ratio 1.25
    Return on Assets (%) -4.79
    Return on Capital (%) -5.04
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 12.76
    Total Liabilities 12.76
    Total Equity 8.92
    Share Outstanding 1
    Price to Book Ratio 1.67
    Return on Assets (%) 0.18
    Return on Capital (%) 0.26
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 8.98
    Total Liabilities 8.98
    Total Equity 8.90
    Share Outstanding 1
    Price to Book Ratio 1.61
    Return on Assets (%) -29.11
    Return on Capital (%) -29.4
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 11.60
    Total Liabilities 11.60
    Total Equity 11.52
    Share Outstanding 1
    Price to Book Ratio 4.64
    Return on Assets (%) 3.10
    Return on Capital (%) 3.13
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 11.39
    Total Liabilities 11.39
    Total Equity 11.16
    Share Outstanding 1
    Price to Book Ratio 3.03
    Return on Assets (%) 0.84
    Return on Capital (%) 0.85
    Particulars MAR 2025 (Values in Cr)
    Net Income -6.38
    Cash from Operations -9.81
    Cash from Investing 3.06
    Cash from Financing 0.24
    Net change in Cash -6.50
    Free Cash Flow -9.76
    Particulars MAR 2024 (Values in Cr)
    Net Income -1.21
    Cash from Operations 4.85
    Cash from Investing -1.79
    Cash from Financing -1.16
    Net change in Cash 1.89
    Free Cash Flow 4.91
    Particulars MAR 2023 (Values in Cr)
    Net Income -4.15
    Cash from Operations -1.56
    Cash from Investing -4.27
    Cash from Financing -2.15
    Net change in Cash -7.99
    Free Cash Flow -0.78
    Particulars MAR 2022 (Values in Cr)
    Net Income 12.35
    Cash from Operations 8.26
    Cash from Investing -0.45
    Cash from Financing 1.30
    Net change in Cash 9.11
    Free Cash Flow 8.46
    Particulars MAR 2021 (Values in Cr)
    Net Income 2.14
    Cash from Operations 1.83
    Cash from Investing -0.31
    Cash from Financing 3.98
    Net change in Cash 5.50
    Free Cash Flow 2.14
    Particulars MAR 2025 (Values in Cr)
    Net Income -0.43
    Cash from Operations 0.07
    Cash from Investing -0.04
    Cash from Financing 0.00
    Net change in Cash 0.02
    Free Cash Flow 0.13
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.02
    Cash from Operations -0.02
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash -0.02
    Free Cash Flow -0.02
    Particulars MAR 2023 (Values in Cr)
    Net Income -2.63
    Cash from Operations -0.07
    Cash from Investing 0.08
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow -0.07
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.35
    Cash from Operations 0.54
    Cash from Investing -0.38
    Cash from Financing -0.13
    Net change in Cash 0.02
    Free Cash Flow 0.67
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.10
    Cash from Operations 0.27
    Cash from Investing -0.18
    Cash from Financing -0.09
    Net change in Cash -0.01
    Free Cash Flow 0.46
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 14.47 1.68 267.22 23.12 38.85
    BLISS GVS PHARMA LTD. 467.40 37.63 4.16 4965.84 118.35 552.90
    CIPLA LTD 1472.95 33.25 3.45 118991.58 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 501.25 23.44 3.62 1475.23 256.40 507.20
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 24.38 4.49 267.22 23.12 38.85
    AMRUTAJAN HEALTH LTD 515.00 23.08 4.02 1488.90 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8103.65 105.90 23.21 20259.13 7630.00 9850.00
    BLISS GVS PHARMA LTD. 467.40 50.58 4.29 4965.84 118.35 552.90

    DECIPHER LABS LIMITED shareholding pattern

    Holding
    83.57%
    16.42%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    DECIPHER LABS LIMITED Technicals Summary

    6.85 8.21 redarrow
    red-green-graph indicator
    3 Bearish
    13 Bullish
    • 5 Days 6.10
    • 26 Days 6.40
    • 10 Days 6.20
    • 50 Days 6.60
    • 12 Days 6.20
    • 100 Days 7.00
    • 20 Days 6.30
    • 200 Days 8.00
    6.37 PIVOT
    First Support 6.29 First Resistance 6.40 Second Support 6.26 Second Resistance 6.48 Third Support 6.18 Third Resistance 6.51
    RSI 48.98 ADX 26.08 MACD -0.18 Williams % R -43.51 Commodity Channel Index (CCI) 16.17
    Date 2026-07-31 Week 2584.00 Same Day 1692.00 Month 3847.00
    1 Year 0.99 3 Year 0.62
    Over 1 Month
    -5.66% down
    Over 1 Year
    -41.65% down
    Over 3 Months
    -20.87% down
    Over 3 Years
    -26.72% down
    Over 6 Months
    -20.97% down
    Over 5 Years
    -29.97% down

    DECIPHER LABS LIMITED Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Decipher Labs Ltd?

    Answer Field

    Decipher Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 6.85 as on Aug 03 2026 11:30 AM.

    What is the Market Cap of Decipher Labs Ltd Share?

    Answer Field

    The market cap of Decipher Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 6.90 as on Aug 03 2026 11:30 AM.

    What is the 52 Week High and Low of Decipher Labs Ltd?

    Answer Field

    The 52 Week High and Low of Decipher Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 11.66 and ₹ 5.00.

    What is 1 year return for Decipher Labs Ltd?

    Answer Field

    The 1 year returns on the stock has been -41.65%.

    What is the P/E Ratio of Decipher Labs Ltd Share?

    Answer Field

    As on Aug 03 2026 11:30 AM the price-to-earnings (PE) ratio for Decipher Labs Ltd share is -26.38.

    What is the PB ratio of Decipher Labs Ltd Share?

    Answer Field

    As on Aug 03 2026 11:30 AM, the price-to-book (PB) ratio for Decipher Labs Ltd share is 8.15.

    How to Buy Decipher Labs Ltd Share?

    Answer Field

    You can trade in Decipher Labs Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Decipher Labs Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Decipher Labs Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Decipher Labs Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |